High Tech Pharm Co

High Tech Pharm Co Net Debt per Share

The Net Debt per Share of High Tech Pharm Co (106190.KQ) as of Nov 3, 2026 is 22.86 KRW. In the previous year, Net Debt per Share was 1,047.24 KRW — a change of -97.82% (lower).

Net Debt per Share

22.86KRW

YoY

-97.82%

Last updated:

Net Debt per Share of High Tech Pharm Co is 2024 22.86 KRW. Net Debt per Share of High Tech Pharm Co was 2023 1,047.24 KRW. It decreases by -97.82% lower compared to the previous year.

The High Tech Pharm Co Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2017
-216.76 KRW
Jan 1, 2018
307.62 KRW
Jan 1, 2019
45.52 KRW
Jan 1, 2020
888.40 KRW
Jan 1, 2021
314.17 KRW
Jan 1, 2022
803.51 KRW
Jan 1, 2023
1,047.24 KRW
Jan 1, 2024
22.86 KRW
The High Tech Pharm Co Net Debt per Share history
YEARNet Debt per ShareYoY
22.86KRW-97.82%
1,047.24KRW+30.33%
803.51KRW+155.76%
314.17KRW-64.64%
888.40KRW+1,851.64%
45.52KRW-85.20%
307.62KRW-241.92%
-216.76KRW-75.48%
-884.07KRW-70.84%
-3,031.34KRW-1,094.79%
304.72KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

High Tech Pharm Co Stock analysis

What does High Tech Pharm Co do? High Tech Pharm Co., Ltd. generates revenue by manufacturing and selling raw materials specifically for injectable antibiotic products. The company's product portfolio consists of sterile imipenem, sterile cilastatin sodium, sterile blended imipenem and cilastatin sodium, injectable sterile meropenem, injectable sterile panipenem, faropenem, and other related pharmaceutical ingredients. These items are produced for use in the medical sector as active pharmaceutical components. The firm sells these antibiotic pharmaceutical ingredients to both domestic and overseas markets. As a Korea-based entity, it distributes its sterile products to buyers who require raw materials for injectable formulations. The company operates from its headquarters in Chungju, Chungcheongbuk-Do, where it utilizes its workforce to support this manufacturing and distribution model. High Tech Pharm Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about High Tech Pharm Co stock

Net Debt per Share of High Tech Pharm Co is 22.86 KRW in 2024.

Net Debt per Share of High Tech Pharm Co changed from 1,047.24 KRW to 22.86 KRW, representing a -97.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share High Tech Pharm Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — High Tech Pharm Co

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — High Tech Pharm Co